MTCH
37
7
DVA
72
2
NWSA
62
2
CL
56
5
EFX
32
2
INTU
51
2
TXT
48
2
BMY
53
-7
RSG
68
3
HP
38
-2
COF
55
-3
PSA
51
-4
HON
65
-2
MRK
22
3
AVGO
20
-5
EOG
58
2
DVN
16
3
F
43
-8
GIS
26
3
IBM
54
4
MTCH
37
7
DVA
72
2
NWSA
62
2
CL
56
5
EFX
32
2
INTU
51
2
TXT
48
2
BMY
53
-7
RSG
68
3
HP
38
-2
COF
55
-3
PSA
51
-4
HON
65
-2
MRK
22
3
AVGO
20
-5
EOG
58
2
DVN
16
3
F
43
-8
GIS
26
3
IBM
54
4
Financhill
Back

Treace Medical Concepts Vs. Perspective Therapeutics Industry Stock Comparison

Buy
57

TMCI
Treace Medical Concepts

Last Price:
8.04
Seasonality Move:
44.97%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.29
Seasonality Move:
34.33%
Buy
57
Treace Medical Concepts (TMCI) is a Buy

Is Treace Medical Concepts a Buy, Sell or Hold?

  • The current Treace Medical Concepts [TMCI] share price is $7.98. The Score for TMCI is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • TMCI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $6.17. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TMCI Stock Price Chart

What is Treace Medical Concepts's stock price today?

  • The Treace Medical Concepts share price today is $7.98
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TMCI is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $6.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

TMCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.68 Buy
Relative Strength Index (14 RSI): 69.92 Buy
Chaikin Money Flow: 366057 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.9 - 7.7) Buy
Bollinger Bands (100): (5.16 - 7.38) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.47 Sell
Relative Strength Index (14 RSI): 14.63 Sell
Chaikin Money Flow: -723713 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.98 - 12.88) Sell
Bollinger Bands (100): (10.81 - 14.53) Sell

TMCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.83 Buy
20-day SMA: 6.55 Buy
50-day SMA: 5.82 Buy
200-day SMA: 8.19 Sell
8-day EMA: 7.62 Buy
20-day EMA: 6.93 Buy
50-day EMA: 6.31 Buy
200-day EMA: 8.11 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.55 Sell
20-day SMA: 10.54 Sell
50-day SMA: 12.08 Sell
200-day SMA: 12.78 Sell
8-day EMA: 8.2 Sell
20-day EMA: 9.96 Sell
50-day EMA: 11.52 Sell
200-day EMA: 11.52 Sell

Treace Medical Concepts Earnings Growth & TMCI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.13 per share, and an increase next year of $0.19 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Treace Medical Concepts Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):